Clinical Trials
6 trialsNCT02763319 2025-07-17
B-MIND
Incyte Corporation
Phase 2/3 Completed
NCT03366272 2025-01-28
NIVEAU
Universität des Saarlandes
Phase 2/3 Completed
NCT01197560 2019-11-25
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Celgene
Phase 2/3 Completed
NCT00641095 2018-10-31
MCLPIII
University College, London
Phase 2/3 Completed
NCT00147121 2016-09-22
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
Japan Clinical Oncology Group
Phase 2/3 Completed
NCT00045877 2006-02-06
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
Chiron Corporation
Phase 2/3 Completed